|
TMEM30A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.466500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.644110E-02 |
| Normal-vs-Stage2 |
3.077200E-01 |
| Normal-vs-Stage3 |
4.400800E-01 |
| Normal-vs-Stage4 |
6.470400E-01 |
| Stage1-vs-Stage2 |
5.623200E-01 |
| Stage1-vs-Stage3 |
1.113200E-01 |
| Stage1-vs-Stage4 |
1.873220E-01 |
| Stage2-vs-Stage3 |
6.377600E-01 |
| Stage2-vs-Stage4 |
5.756800E-01 |
| Stage3-vs-Stage4 |
8.242800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.432000E-02 |
| Normal-vs-AfricanAmerican |
3.041600E-02 |
| Normal-vs-Asian |
3.303800E-01 |
| Caucasian-vs-AfricanAmerican |
8.597500E-02 |
| Caucasian-vs-Asian |
8.420600E-01 |
| AfricanAmerican-vs-Asian |
1.169760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.035900E-02 |
| Normal-vs-Female |
5.400400E-02 |
| Male-vs-Female |
9.517800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.082900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.845380E-01 |
| Normal-vs-Age(61-80Yrs) |
7.347800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.062200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.029500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.469700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.432400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.592800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.235000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.026800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.944800E-03 |
| Classical-VS-Follicular |
5.160500E-03 |
| Classical-VS-Other |
3.852200E-01 |
| Classical-VS-Normal |
2.781900E-03 |
| Tall-VS-Follicular |
6.992600E-01 |
| Tall-VS-Other |
7.519600E-01 |
| Tall-VS-Normal |
7.684000E-01 |
| Follicular-VS-Other |
9.452600E-01 |
| Follicular-VS-Normal |
9.206200E-01 |
| Other-VS-Normal |
8.864200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.878800E-01 |
| Normal-vs-N1 |
6.290800E-01 |
| N0-vs-N1 |
7.394600E-01 |
|
|
